Andlauer Healthcare Group Gelecekteki Büyüme

Future kriter kontrolleri 0/6

Andlauer Healthcare Group'in gelirinin artacağı tahmin edilmektedir.

Anahtar bilgiler

n/a

Kazanç büyüme oranı

n/a

EPS büyüme oranı

Healthcare kazanç büyümesi	61.1%
Gelir büyüme oranı	4.6%
Gelecekteki özkaynak getirisi	16.3%
Analist kapsamı	Good
Son güncelleme	07 Nov 2024

Gelecekteki son büyüme güncellemeleri

Recent updates

We Think Andlauer Healthcare Group (TSE:AND) Can Manage Its Debt With Ease

Nov 07

Here's What To Make Of Andlauer Healthcare Group's (TSE:AND) Decelerating Rates Of Return

Oct 17

Andlauer Healthcare Group (TSE:AND) Is Increasing Its Dividend To CA$0.11

Sep 20

Here's Why Andlauer Healthcare Group (TSE:AND) Can Manage Its Debt Responsibly

May 23

These 4 Measures Indicate That Andlauer Healthcare Group (TSE:AND) Is Using Debt Reasonably Well

Jan 30

Return Trends At Andlauer Healthcare Group (TSE:AND) Aren't Appealing

Aug 24

Market Participants Recognise Andlauer Healthcare Group Inc.'s (TSE:AND) Earnings

May 05

We Ran A Stock Scan For Earnings Growth And Andlauer Healthcare Group (TSE:AND) Passed With Ease

Oct 28

These 4 Measures Indicate That Andlauer Healthcare Group (TSE:AND) Is Using Debt Safely

Oct 12

Here's What To Make Of Andlauer Healthcare Group's (TSE:AND) Decelerating Rates Of Return

Aug 17

We Ran A Stock Scan For Earnings Growth And Andlauer Healthcare Group (TSE:AND) Passed With Ease

Jul 19

Andlauer Healthcare Group (TSE:AND) Could Easily Take On More Debt

Jul 05

The Returns At Andlauer Healthcare Group (TSE:AND) Aren't Growing

May 04

I Ran A Stock Scan For Earnings Growth And Andlauer Healthcare Group (TSE:AND) Passed With Ease

Apr 19

Is Andlauer Healthcare Group (TSE:AND) A Risky Investment?

Feb 23

Is There An Opportunity With Andlauer Healthcare Group Inc.'s (TSE:AND) 33% Undervaluation?

Jan 19

We Think Andlauer Healthcare Group (TSE:AND) Might Have The DNA Of A Multi-Bagger

Jan 06

Should You Be Adding Andlauer Healthcare Group (TSE:AND) To Your Watchlist Today?

Dec 15

Kazanç ve Gelir Büyüme Tahminleri

TSX:AND - Analistlerin gelecek tahminleri ve geçmiş finansal verileri (CAD Millions )
Tarih	Gelir	Kazançlar	Serbest Nakit Akışı	Faaliyetlerden Nakit	Avg. Analist Sayısı
12/31/2026	719	N/A	117	155	3
12/31/2025	689	N/A	101	141	6
12/31/2024	653	N/A	100	134	6
9/30/2024	651	66	103	127	N/A
6/30/2024	648	65	101	125	N/A
3/31/2024	644	65	85	113	N/A
12/31/2023	648	66	79	104	N/A
9/30/2023	645	67	87	116	N/A
6/30/2023	653	71	94	125	N/A
3/31/2023	665	76	102	132	N/A
12/31/2022	648	76	109	137	N/A
9/30/2022	616	110	109	129	N/A
6/30/2022	555	103	98	111	N/A
3/31/2022	493	95	85	97	N/A
12/31/2021	440	90	74	84	N/A
9/30/2021	394	51	54	61	N/A
6/30/2021	365	47	52	59	N/A
3/31/2021	328	41	51	58	N/A
12/31/2020	314	38	46	51	N/A
9/30/2020	304	31	64	72	N/A
6/30/2020	299	30	57	65	N/A
3/31/2020	300	31	54	61	N/A
12/31/2019	290	30	55	61	N/A
9/30/2019	285	28	44	49	N/A
12/31/2018	277	27	50	52	N/A
12/31/2017	251	22	N/A	43	N/A
12/31/2016	224	19	N/A	30	N/A

Analist Gelecek Büyüme Tahminleri

Kazançlar ve Tasarruf Oranları: AND 'un tahmini kazanç büyümesinin tasarruf oranının ( 2.3% ) üzerinde olup olmadığını belirlemek için yeterli veri yok.

Kazançlar ve Piyasa: AND 'un kazançlarının Canadian pazarından daha hızlı büyümesinin öngörülüp öngörülmediğini belirlemek için yeterli veri yok

Yüksek Büyüme Kazançları: AND şirketinin kazançlarının önümüzdeki 3 yıl içerisinde önemli ölçüde artıp artmayacağını belirlemek için yeterli veri bulunmuyor.

Gelir ve Pazar: AND şirketinin gelirinin (yıllık 4.6% ) Canadian pazarından (yıllık 7% ) daha yavaş büyümesi öngörülüyor.

Yüksek Büyüme Geliri: AND şirketinin gelirinin (yıllık 4.6% ) yıllık 20% oranından daha yavaş büyümesi öngörülüyor.

Hisse Başına Kazanç Büyüme Tahminleri

Gelecekteki Özkaynak Getirisi

Gelecekteki ROE: AND 'nin Özsermaye Getirisi'nin 3 yıl içinde düşük olması tahmin ediliyor ( 16.3 %).

Andlauer Healthcare Group Gelecekteki Büyüme

Future kriter kontrolleri 0/6

Anahtar bilgiler

Gelecekteki son büyüme güncellemeleri

Price target increased to CA$57.83

Recent updates

Insider recently sold CA$887k worth of stock

We Think Andlauer Healthcare Group (TSE:AND) Can Manage Its Debt With Ease

Third quarter 2024 earnings released: EPS: CA$0.41 (vs CA$0.37 in 3Q 2023)

Here's What To Make Of Andlauer Healthcare Group's (TSE:AND) Decelerating Rates Of Return

Andlauer Healthcare Group Inc. to Report Q3, 2024 Results on Nov 05, 2024

Andlauer Healthcare Group (TSE:AND) Is Increasing Its Dividend To CA$0.11

Second quarter dividend of CA$0.11 announced

Andlauer Healthcare Announces Third Quarter Dividend, Payable on October 15, 2024

President of Specialty Solutions recently sold CA$211k worth of stock

Second quarter 2024 earnings released: EPS: CA$0.38 (vs CA$0.38 in 2Q 2023)

Andlauer Healthcare Group Inc. to Report Q2, 2024 Results on Jul 31, 2024

Chairman of the Board recently sold CA$970k worth of stock

First quarter dividend of CA$0.10 announced

Andlauer Healthcare Announces Second Quarter Dividend, Payable on July 15, 2024

President of Specialty Solutions recently sold CA$791k worth of stock

Chairman of the Board exercised options to buy CA$3.8m worth of stock.

Here's Why Andlauer Healthcare Group (TSE:AND) Can Manage Its Debt Responsibly

Andlauer Healthcare Group Inc. (TSX:AND) announces an Equity Buyback for 2,000,000 shares, representing 4.8% for CAD 90 million.

President of Specialty Solutions exercised options to buy CA$1.3m worth of stock.

First quarter 2024 earnings released: EPS: CA$0.36 (vs CA$0.39 in 1Q 2023)

Andlauer Healthcare Group Inc. to Report Q1, 2024 Results on May 02, 2024

Fourth quarter dividend of CA$0.10 announced

Andlauer Healthcare Group Inc. Provides Quarterly Dividend Guidance

Full year 2023 earnings released: EPS: CA$1.58 (vs CA$1.82 in FY 2022)

Andlauer Healthcare Group Inc., Annual General Meeting, May 03, 2024

Andlauer Healthcare Group Inc. to Report Q4, 2023 Results on Mar 05, 2024

These 4 Measures Indicate That Andlauer Healthcare Group (TSE:AND) Is Using Debt Reasonably Well

Andlauer Healthcare Group Inc. Announces Board Changes

Chairman of the Board recently bought CA$768k worth of stock

Chairman of the Board recently sold CA$774k worth of stock

Third quarter 2023 earnings released: EPS: CA$0.37 (vs CA$0.45 in 3Q 2022)

Andlauer Healthcare Group Inc. to Report Q3, 2023 Results on Nov 02, 2023

Upcoming dividend of CA$0.09 per share at 0.8% yield

Andlauer Healthcare Group Inc. Announces the Third Quarter Shareholder Dividend, Payable on October 16, 2023

Return Trends At Andlauer Healthcare Group (TSE:AND) Aren't Appealing

Andlauer Healthcare Group Inc. Intends to Declare Quarterly Dividend

Second quarter 2023 earnings released: EPS: CA$0.37 (vs CA$0.50 in 2Q 2022)

Andlauer Healthcare Group Inc. to Report Q2, 2023 Results on Aug 01, 2023

Andlauer Healthcare Group Inc. Announces Dividend for the Second Quarter Period from April 1, 2023 to June 30, 2023, Payable on July 17, 2023

Insider recently sold CA$9.8m worth of stock

Insider recently sold CA$242k worth of stock

Now 20% undervalued after recent price drop

Now 21% undervalued after recent price drop

First quarter 2023 earnings released: EPS: CA$0.39 (vs CA$0.40 in 1Q 2022)

Andlauer Healthcare Group Inc. Appoints Graham Cromb as Chief Strategy Officer

Market Participants Recognise Andlauer Healthcare Group Inc.'s (TSE:AND) Earnings

Is Andlauer Healthcare Group (TSE:AND) Using Too Much Debt?

President of Transportation recently sold CA$709k worth of stock

Upcoming dividend of CA$0.08 per share at 0.6% yield

Full year 2022 earnings released: EPS: CA$1.82 (vs CA$2.30 in FY 2021)

Andlauer Healthcare Group Inc., Annual General Meeting, May 04, 2023

Andlauer Healthcare Group Inc. to Report Q4, 2022 Results on Mar 02, 2023

President of Transportation recently sold CA$243k worth of stock

A Look At The Fair Value Of Andlauer Healthcare Group Inc. (TSE:AND)

Andlauer Healthcare Group Inc. Announces Fourth Quarter Dividend, Payable on January 16, 2023

Andlauer Healthcare Group (TSE:AND) Hasn't Managed To Accelerate Its Returns

Insider recently sold CA$595k worth of stock

Insufficient new directors

Third quarter 2022 earnings released: EPS: CA$0.45 (vs CA$0.32 in 3Q 2021)

We Ran A Stock Scan For Earnings Growth And Andlauer Healthcare Group (TSE:AND) Passed With Ease

Andlauer Healthcare Group Inc. to Report Q3, 2022 Results on Nov 08, 2022

These 4 Measures Indicate That Andlauer Healthcare Group (TSE:AND) Is Using Debt Safely

Andlauer Healthcare Group Inc. Announces Dividend for the Period from July 1, 2022 to September 30, 2022, Payable on October 17, 2022

Insider recently sold CA$358k worth of stock

President of Specialty Solutions recently sold CA$448k worth of stock

Here's What To Make Of Andlauer Healthcare Group's (TSE:AND) Decelerating Rates Of Return

Investor sentiment improved over the past week

Price target increased to CA$57.83

Second quarter 2022 earnings released

Andlauer Healthcare Group Inc. Provides Dividend Guidance for Quarterly Dividend

We Ran A Stock Scan For Earnings Growth And Andlauer Healthcare Group (TSE:AND) Passed With Ease

Andlauer Healthcare Group Inc. to Report Q2, 2022 Results on Aug 09, 2022

Andlauer Healthcare Group (TSE:AND) Could Easily Take On More Debt

Upcoming dividend of CA$0.06 per share